Michelle Turner
Overview
Explore the profile of Michelle Turner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
1653
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Turner M, Holdsworth S
Scand J Psychol
. 2024 May;
65(5):816-826.
PMID: 38711221
Introduction: Students can expect to experience stressors associated with their studies that can have detrimental effects on their mental well-being if not properly managed. Drawing on a positive psychology paradigm,...
2.
Hsu M, Boulanger M, Olson S, Eaton C, Prichett L, Guo M, et al.
JAMA Netw Open
. 2024 Apr;
7(4):e246872.
PMID: 38630475
Importance: Despite a growing population of survivors of lung cancer, there is limited understanding of the survivorship journey. Survivors of lung cancer experience unmet physical, social, emotional, and medical needs...
3.
Hsu M, Guo M, Olson S, Eaton C, Boulanger M, Turner M, et al.
J Natl Compr Canc Netw
. 2024 Jan;
22(1D):e237072.
PMID: 38176099
Background: Newer therapies prolong survival for patients with lung cancer. Beyond extending survival, the needs of lung cancer (LC) survivors are poorly described. Methods: We conducted a single-institution needs assessment...
4.
Naidoo J, Murphy C, Atkins M, Brahmer J, Champiat S, Feltquate D, et al.
J Immunother Cancer
. 2023 Mar;
11(3).
PMID: 37001909
Immune-related adverse events (irAEs) associated with immune checkpoint inhibitor (ICI) therapy may vary substantially in their clinical presentation, including natural history, outcomes to treatment, and patterns. The application of clinical...
5.
Stoll K, Titoria R, Turner M, Jones A, Butska L
CMAJ
. 2023 Feb;
195(8):E292-E299.
PMID: 36849178
Background: Anecdotal evidence suggests that the profile of midwifery clients in British Columbia has changed over the past 20 years and that midwives are increasingly caring for clients with moderate...
6.
Wingler M, Cretella D, Wagner J, Barber K, Bookstaver P, Jones B, et al.
J Am Pharm Assoc (2003)
. 2022 Sep;
62(6):1756-1760.
PMID: 36115761
Pharmacy residency recruitment and interviews have been significantly impacted by the COVID-19 pandemic. Many traditional recruitment events and interviews were transitioned from in-person to virtual, and new approaches to recruitment,...
7.
Hsu M, Murray J, Psoter K, Zhang J, Barasa D, Brahmer J, et al.
Oncologist
. 2022 Aug;
27(11):971-981.
PMID: 35972337
Introduction: Anti-PD-(L)1 immune checkpoint inhibitors (ICI) improve survival in patients with advanced non-small cell lung cancer (aNSCLC). The clinical features, survival, and burden of toxicities of patients with aNSCLC alive...
8.
Wingler M, Cretella D, Wagner J, Barber K, Bookstaver P, Freeman L, et al.
J Am Coll Clin Pharm
. 2022 Aug;
PMID: 35942359
Introduction: Due to the COVID-19 pandemic, most pharmacy residency programs changed to an all-virtual format for recruitment and interviews for the 2020-2021 application cycle. There are no data evaluating the...
9.
Liang K, Tackett S, Myers S, Brahmer J, Browner I, Ettinger D, et al.
Curr Oncol
. 2022 Jun;
29(6):4342-4353.
PMID: 35735456
Introduction: With the increasing use of immune checkpoint inhibitors (ICI) for cancer, there is a growing burden on the healthcare system to provide care for the toxicities associated with these...
10.
Strong L, Middendorf I, Turner M, Edwards V D, Sama V, Mou J, et al.
JMIR Hum Factors
. 2021 Oct;
8(4):e29234.
PMID: 34609947
Background: Readily available testing for SARS-CoV-2 is necessary to mitigate COVID-19 disease outbreaks. At-home collection kits, in which samples are self-collected without requiring a laboratory or clinic visit and sent...